Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study.
Epilepsy is the most common neurological disorder in both dogs and humans. Although the pharmacological options for treatment of epilepsies have increased, it has been reported that two-thirds of dogs with epilepsy are refractory to antiepileptic drug therapy. To our knowledge, there are no experimental studies in the literature that show an effect of omega-3 supplementation on epilepsy in dogs. Our case study describes the effectiveness of daily intake of a moderate amount of fish oil in a case of canine epilepsy.
Scorza
Fulvio A
FA
Disciplina de Neurologia Experimental, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, Brazil. scorza.nexp@epm.br
Cavalheiro
Esper A
EA
Arida
Ricardo M
RM
Terra
Vera C
VC
Scorza
Carla A
CA
Ribeiro
Miriam O
MO
Cysneiros
Roberta M
RM
D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D001522:Behavior, Animal; D019587:Dietary Supplements; D004283:Dog Diseases / Q000188:drug therapy* / Q000523:psychology; D004285:Dogs; D004351:Drug Resistance; D004827:Epilepsy / Q000188:drug therapy* / Q000523:psychology / Q000662:veterinary*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D005260:Female; D010634:Phenobarbital / Q000627:therapeutic use
D000927:Anticonvulsants; D015525:Fatty Acids, Omega-3; D010634:Phenobarbital